AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Clinical trials for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA explained in plain language.
Never miss a new study
Get alerted when new AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA trials appear
Sign up with your email to follow new studies for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for calming Alzheimer's agitation
Symptom relief Recruiting nowThis study is testing two new drugs, EXV-802 and EXV-801, to see if they can safely reduce agitation in people with Alzheimer's dementia. About 300 participants, aged 55-90, will be randomly assigned to receive one of the drugs or a placebo for 6 weeks. The main goal is to see if…
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2, PHASE3 • Sponsor: Exciva GmbH • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
New drug trial targets distressing agitation in Alzheimer's patients
Symptom relief Recruiting nowThis study is testing whether an investigational medicine called ONO-2020 can safely reduce agitation in people with Alzheimer's disease dementia. It will involve about 90 patients in Japan who will be randomly assigned to receive either the drug or a placebo while hospitalized. …
Matched conditions: AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co. Ltd • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC